Emma L. Veale

8.3k total citations · 4 hit papers
57 papers, 4.4k citations indexed

About

Emma L. Veale is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Emma L. Veale has authored 57 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 25 papers in Cellular and Molecular Neuroscience and 22 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Emma L. Veale's work include Ion channel regulation and function (36 papers), Neuroscience and Neuropharmacology Research (24 papers) and Cardiac electrophysiology and arrhythmias (17 papers). Emma L. Veale is often cited by papers focused on Ion channel regulation and function (36 papers), Neuroscience and Neuropharmacology Research (24 papers) and Cardiac electrophysiology and arrhythmias (17 papers). Emma L. Veale collaborates with scholars based in United Kingdom, Australia and United States. Emma L. Veale's co-authors include Alistair Mathie, Elena Faccenda, Jamie A. Davies, Eamonn Kelly, Jane F Armstrong, Simon D Harding, John A. Peters, S P H Alexander, Adam J Pawson and Christopher Southan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Emma L. Veale

56 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors

2019 639 citations S P H Alexander, Arthur Christopoulos et al. British Journal of Pharmacology profile →
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes

2019 485 citations S P H Alexander, Doriano Fabbro et al. British Journal of Pharmacology profile →
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets

2019 397 citations S P H Alexander, Eamonn Kelly et al. British Journal of Pharmacology profile →
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels

2019 291 citations S P H Alexander, Alistair Mathie et al. British Journal of Pharmacology profile →

Peers

Countries citing papers authored by Emma L. Veale

Since Specialization

Citations

This map shows the geographic impact of Emma L. Veale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma L. Veale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma L. Veale more than expected).

Fields of papers citing papers by Emma L. Veale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma L. Veale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma L. Veale. The network helps show where Emma L. Veale may publish in the future.

Co-authorship network of co-authors of Emma L. Veale

This figure shows the co-authorship network connecting the top 25 collaborators of Emma L. Veale. A scholar is included among the top collaborators of Emma L. Veale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma L. Veale. Emma L. Veale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Concise Guide to PHARMACOLOGY 2023/24: Nuclear hormone receptors 2023 ·British Journal of Pharmacology ·S P H Alexander, John A. Cidlowski, Eamonn Kelly, Alistair Mathie, John A. Peters, Emma L. Veale, Jane F Armstrong, Elena Faccenda, Simon D Harding, Jamie A. Davies, Laurel A. Coons, Peter J. Fuller, Kenneth S. Korach, Morag J. Young	56
2	A KCNB1 gain of function variant causes developmental delay and speech apraxia but not seizures 2022 ·Frontiers in Pharmacology ·Emma L. Veale, (unknown), Katheryn Grand, John M. Graham, Alistair Mathie	6
3	THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Nuclear hormone receptors 2021 ·British Journal of Pharmacology ·S P H Alexander, John A. Cidlowski, Eamonn Kelly, Alistair Mathie, John A. Peters, Emma L. Veale, Jane F Armstrong, Elena Faccenda, Simon D Harding, Adam J Pawson, Christopher Southan, Jamie A. Davies, Laurel A. Coons, Peter J. Fuller, Kenneth S. Korach, Morag J. Young	105
4	Aprepitant is a novel, selective activator of the K2P channel TRAAK 2021 ·Biochemical and Biophysical Research Communications ·(unknown), Emma L. Veale, (unknown), (unknown), (unknown), Jonathan M. Large, (unknown), (unknown), Jeffrey C. Jerman, Alistair Mathie, Paul D. Wright	4
5	The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels 2021 ·Frontiers in Pharmacology ·(unknown), Lucie H. Clapp, Alistair Mathie, Emma L. Veale	5
6	Opportunistic screening for atrial fibrillation by clinical pharmacists in UK general practice during the influenza vaccination season: A cross-sectional feasibility study 2020 ·PLoS Medicine ·Vilius Savickas, (unknown), Melanie Rees-Roberts, Vanessa L. Short, (unknown), Sarah Corlett, Alistair Mathie, Emma L. Veale	12
7	Effects of the ventilatory stimulant, doxapram on human TASK‐3 (KCNK9, K2P9.1) channels and TASK‐1 (KCNK3, K2P3.1) channels 2019 ·Acta Physiologica ·(unknown), D. Euan MacIntyre, Alistair Mathie, Emma L. Veale	17
8	THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes breakdown → 2019 ·British Journal of Pharmacology ·S P H Alexander, Doriano Fabbro, Eamonn Kelly, Alistair Mathie, John A. Peters, Emma L. Veale, Jane F Armstrong, Elena Faccenda, Simon D Harding, Adam J Pawson, Joanna L Sharman, Christopher Southan, Jamie A. Davies, (unknown)	485
9	THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters 2019 ·British Journal of Pharmacology ·S P H Alexander, Eamonn Kelly, Alistair Mathie, John A. Peters, Emma L. Veale, Jane F Armstrong, Elena Faccenda, Simon D Harding, Adam J Pawson, Joanna L Sharman, Christopher Southan, Jamie A. Davies, (unknown)	209
10	THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets. 2019 ·Apollo (University of Cambridge) ·S P H Alexander, Eamonn Kelly, Alistair Mathie, John A. Peters, Emma L. Veale, Jane F Armstrong, Elena Faccenda, Simon D Harding, Adam J Pawson, Joanna L Sharman, Christopher Southan, O. Buneman, John A. Cidlowski, Arthur Christopoulos, Anthony P. Davenport, Doriano Fabbro, Michael Spedding, Jörg Striessnig, Jamie A. Davies, (unknown)	0
11	THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic receptors 2019 ·British Journal of Pharmacology ·S P H Alexander, Doriano Fabbro, Eamonn Kelly, Alistair Mathie, John A. Peters, Emma L. Veale, Jane F Armstrong, Elena Faccenda, Simon D Harding, Adam J Pawson, Joanna L Sharman, Christopher Southan, Jamie A. Davies, (unknown)	187
12	THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Nuclear hormone receptors 2019 ·British Journal of Pharmacology ·S P H Alexander, John A. Cidlowski, Eamonn Kelly, Alistair Mathie, John A. Peters, Emma L. Veale, Jane F Armstrong, Elena Faccenda, Simon D Harding, Adam J Pawson, Joanna L Sharman, Christopher Southan, Jamie A. Davies, (unknown)	148
13	THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors breakdown → 2019 ·British Journal of Pharmacology ·S P H Alexander, Arthur Christopoulos, Anthony P. Davenport, Eamonn Kelly, Alistair Mathie, John A. Peters, Emma L. Veale, Jane F Armstrong, Elena Faccenda, Simon D Harding, Adam J Pawson, Joanna L Sharman, Christopher Southan, Jamie A. Davies, (unknown)	639
14	THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels breakdown → 2019 ·British Journal of Pharmacology ·S P H Alexander, Alistair Mathie, John A. Peters, Emma L. Veale, Jörg Striessnig, Eamonn Kelly, Jane F Armstrong, Elena Faccenda, Simon D Harding, Adam J Pawson, Joanna L Sharman, Christopher Southan, Jamie A. Davies, (unknown)	291
15	Pranlukast is a novel small molecule activator of the two-pore domain potassium channel TREK2 2019 ·Biochemical and Biophysical Research Communications ·Paul D. Wright, (unknown), (unknown), Jonathan M. Large, (unknown), (unknown), (unknown), Emma L. Veale, Jeff Jerman, Alistair Mathie	16
16	Influence of the N Terminus on the Biophysical Properties and Pharmacology of TREK1 Potassium Channels 2014 ·Molecular Pharmacology ·Emma L. Veale, (unknown), (unknown), Kiyoyuki Omoto, Lishuang Cao, Stephen J. Tucker, Edward B. Stevens, Alistair Mathie	50
17	Recovery of Current through Mutated TASK3 Potassium Channels Underlying Birk Barel Syndrome 2013 ·Molecular Pharmacology ·Emma L. Veale, (unknown), (unknown), (unknown), Alistair Mathie	32
18	Dominant Negative Effects of a Non-conducting TREK1 Splice Variant Expressed in Brain* 2010 ·Journal of Biological Chemistry ·Emma L. Veale, (unknown), Alistair Mathie, Stefan Trapp	36
19	The in Vivo Contributions of TASK-1-Containing Channels to the Actions of Inhalation Anesthetics, the α2 Adrenergic Sedative Dexmedetomidine, and Cannabinoid Agonists 2006 ·Journal of Pharmacology and Experimental Therapeutics ·A. Linden, M. Isabel Aller, Elli Leppä, Olga Vekovischeva, Teemu Aitta‐aho, Emma L. Veale, Alistair Mathie, Per H. Rosenberg, William Wisden, Esa R. Korpi	68
20	What are the roles of the many different types of potassium channel expressed in cerebellar granule cells? 2003 ·The Cerebellum ·Alistair Mathie, Emma L. Veale, Catherine E. Clarke, Kishani M. Ranatunga	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact